Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01758744 · ClinicalTrials.gov registry record · Phase 1
Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
A Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01758744 is a Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 10 participants.
The verdict
NCT01758744, a Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
An Open Label, Pilot Study Testing the Safety and Efficacy of Inhaled Treprostinil (Tyvaso®) in the Treatment of Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD)
Interventions
- DRUG Inhaled Treprostinil Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01758744
The ClinicalTrials.gov registry entry for NCT01758744 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inhaled Treprostinil Therapy is the first listed.
NCT01758744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01758744 about?
NCT01758744 is a clinical study titled "Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1". An Open Label, Pilot Study Testing the Safety and Efficacy of Inhaled Treprostinil (Tyvaso®) in the Treatment of Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD)
What is the current status of trial NCT01758744?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2012-12. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01758744?
The interventions under investigation include: Inhaled Treprostinil Therapy (DRUG).
Who is sponsoring clinical trial NCT01758744?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.